Eli Lilly and Company (LLY.US) 1Q26 Profit Surges 1.7x YoY to USD7.4B, Beats; Raises FY Guidance; Shares Up 6% Pre-Mkt

Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

Eli Lilly and Company Reports Earnings Results for the First Quarter Ended March 31, 2026

Lilly clocks 56% revenue increase in Q1 but declining prices stunt growth

Eli Lilly (LLY) Is Down 7.6% After Upbeat Q1 And Foundayo Approval - What's Changed

Eli Lilly Shares Jump On Guidance Boost, Earnings Above Expectations

Eli Lilly (Q1 2026 earnings: revenue jumps 56% to $19.8B

Lilly CEO shades amylin rivals AbbVie, Pfizer in cutthroat battle for obesity’s next act

Earnings Flash (LLY) Eli Lilly and Company Reports Q1 Revenue $19.80B, vs. FactSet Est of $17.82B

Earnings Flash (LLY) Eli Lilly and Company Posts Q1 Adjusted EPS $8.55 per Share, vs. FactSet Est of $6.97

Eli Lilly stock rises on Q1 2026 results (LLY:NYSE)

Eli Lilly (NYSE: LLY) posts 56% Q1 revenue jump and lifts 2026 EPS outlook

After regulator bust fake Mounjaro racket, Eli Lilly warns patients against unauthorised purchases

Eli Lilly Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Eli Lilly and Company (Derivatives) Exchanges LLY Markets | Buy & Sell & Trade